Equity - Additional Information (Details)	1 Months Ended	12 Months Ended
	Dec. 31, 2022 USD ($)	Dec. 31, 2024 USD ($) $ / shares shares	Dec. 31, 2023 USD ($) shares	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2021 $ / shares shares	Aug. 31, 2022 shares
Equity [Line Items]
Shares issued, net of forfeitures (in shares)		1,669,211	1,284,704	930,602
Number of shares authorized to be repurchased (in shares)						10,000,000
Average cost per share (in dollars per share) | $ / shares				$ 10.78
Remaining authorized repurchase amount (in shares)		6,874,241
Preferred shares outstanding (in shares)		1,935,400	1,935,400
Preferred shares, liquidation preference | $		$ 96,770,000	$ 96,770,000
Shares issued for units redeemed (in shares)			832,571	39,747
Partners' capital account, exchanges and conversions | $			$ 3,393,000	$ 211,000
Exchange ratio of partner units (in shares)			1.13
Variable Interest Entity, Primary Beneficiary | LCIF Partnership
Equity [Line Items]
Common shares issued (in shares)			822,627
Value of shares redeemed | $			$ 7,800,000
Common Stock
Equity [Line Items]
Repurchase of common shares (in shares)		0	0	12,102,074
Preferred shares - Series C
Equity [Line Items]
Preferred shares outstanding (in shares)		1,935,400
Dividend rate (usd per share) | $ / shares		$ 3.25
Preferred shares, liquidation preference | $		$ 96,770,000
Convertible preferred stock, conversion ratio		2.4339
Preferred stock conversion, threshold conversion price percentage (at least)		125.00%
Forward Contracts
Equity [Line Items]
Sale of stock, number of shares issued (in shares)				3,649,023
Sale of stock, net proceeds | $		$ 38,492,000
At-The-Market Offering
Equity [Line Items]
Sale of stock, authorized amount | $	$ 350,000,000			$ 350,000,000
Underwritten Offering
Equity [Line Items]
Sale of stock, number of shares issued (in shares)					16,000,000
Sale of stock (in dollars per share) | $ / shares					$ 12.11
Underwritten Offering | Forward Contracts
Equity [Line Items]
Sale of stock, net proceeds | $	$ 183,419,000